Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Invested Capital: 2019-2024

  • CureVac N.V's Invested Capital rose 30.74% to $786.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $786.0 million, marking a year-over-year increase of 30.74%. This contributed to the annual value of $786.0 million for FY2024, which is 30.74% up from last year.
  • Per CureVac N.V's latest filing, its Invested Capital stood at $786.0 million for Q4 2024, which was up 30.74% from $601.2 million recorded in Q4 2023.
  • In the past 5 years, CureVac N.V's Invested Capital registered a high of $914.0 million during Q4 2020, and its lowest value of $587.0 million during Q4 2022.
  • Its 3-year average for Invested Capital is $658.1 million, with a median of $601.2 million in 2023.
  • In the last 5 years, CureVac N.V's Invested Capital soared by 2,171.97% in 2020 and then dropped by 28.47% in 2022.
  • Over the past 5 years, CureVac N.V's Invested Capital (Quarterly) stood at $914.0 million in 2020, then declined by 10.22% to $820.6 million in 2021, then decreased by 28.47% to $587.0 million in 2022, then grew by 2.42% to $601.2 million in 2023, then spiked by 30.74% to $786.0 million in 2024.
  • Its Invested Capital was $786.0 million in Q4 2024, compared to $601.2 million in Q4 2023 and $587.0 million in Q4 2022.